Bio-Rad Laboratories (BIO.B) Set to Announce Quarterly Earnings on Wednesday

Bio-Rad Laboratories (NYSE:BIO.B) is set to issue its quarterly earnings data after the market closes on Wednesday, October 30th.

Bio-Rad Laboratories (NYSE:BIO.B) last issued its quarterly earnings results on Thursday, August 1st. The company reported $3.11 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a negative net margin of 51.73% and a positive return on equity of 3.77%. The company had revenue of $638.48 million during the quarter.

Bio-Rad Laboratories Stock Performance

NYSE:BIO.B opened at $334.85 on Tuesday. The firm has a market capitalization of $9.55 billion, a P/E ratio of -32.32 and a beta of 0.73. The company has a debt-to-equity ratio of 0.18, a current ratio of 6.28 and a quick ratio of 4.63. Bio-Rad Laboratories has a one year low of $271.00 and a one year high of $352.91. The company’s 50-day simple moving average is $329.69 and its 200 day simple moving average is $304.75.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.